Status:
COMPLETED
The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
Lead Sponsor:
Hawaii Pacific Health
Collaborating Sponsors:
Hawaii Community Foundation
Hawaii Medical Service Association
Conditions:
Respiratory Distress Syndrome, Newborn
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combinat...
Detailed Description
Introduction: In recent years there has been an increased use of nasal continuous positive airway pressure (nCPAP) in the management of premature infants with respiratory distress syndrome (RDS). The ...
Eligibility Criteria
Inclusion
- Gestational age \< 33 weeks
- Receiving CPAP from the time of delivery
Exclusion
- Cyanotic congenital heart disease
- Congenital malformation
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00739115
Start Date
September 1 2008
End Date
August 1 2011
Last Update
August 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States, 96826